Reuters logo
BRIEF-Sinobioway Consortium provides update on acquiring Sinovac Biotech at $8 per share
September 29, 2017 / 12:10 PM / in 19 days

BRIEF-Sinobioway Consortium provides update on acquiring Sinovac Biotech at $8 per share

Sept 29 (Reuters) - Sinovac Biotech Ltd

* Sinobioway Consortium provides update on acquiring Sinovac Biotech (Nasdaq: SVA) at the purchase price of $8 per share

* Shandong Sinobioway Biomedicine-deal to be funded by offshore US dollars not subject to relevant governmental approval or foreign exchange supervision​

* Shandong Sinobioway Biomedicine says Sinobioway Consortium has sent all new documents required by special committee in September 1​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below